Smoking Cessation and Related Indications: Developing Nicotine Replacement Therapy Drug Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 1, 2023
April 11, 2024
bdeb89b0-5451-4478-b053-64d1decc6de0
Related Documents
Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Eosinophilic Esophagitis: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentSeptember 15, 2020Center for Drug Evaluation and Research
Uncomplicated Urinary Tract Infections: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox